Orphanin FQ/nociceptin blocks chronic morphine-induced tyrosine hydroxylase upregulation

Molecular Brain Research

Volumn 105, Issue 1-2, 2002, Pages 38-46

  Thakker, Deepak R ^a   Standifer, Kelly M ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

BE(2) C; ERK; Human neuroblastoma cell; Mu opioid receptor; ORL1; SH SY5Y

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MORPHICEPTIN[3 (N METHYLPHENYLALANINE) 4 DEXTRO PROLINAMIDE]; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NOCICEPTIN; OCTAMER TRANSCRIPTION FACTOR 2; OPIATE RECEPTOR; TRANSCRIPTION FACTOR; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; CELL LEVEL; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABUSE; DRUG EFFECT; DRUG EXPOSURE; ENZYME ACTIVATION; ENZYME REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; RECEPTOR UPREGULATION; REGULATORY MECHANISM;

BRAIN; CATECHOLAMINES; CHRONIC DISEASE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHINE; MORPHINE DEPENDENCE; NEURONS; OCTAMER TRANSCRIPTION FACTOR-2; OPIOID PEPTIDES; RECEPTORS, OPIOID; RECEPTORS, OPIOID, MU; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TYROSINE 3-MONOOXYGENASE; UP-REGULATION;

EID: 0037200779     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00390-X     Document Type: Article

References (48)

1. Becker J.A.J., Wallace A., Garzon A., Ingallinella P., Bianchi E., Cortese R., Simonin F., Kieffer B.L., Pessi A. Ligands for κ-opioid, and ORL1 receptors identified from a conformationally constrained peptide combinatorial library. J. Biol. Chem. 274:1999;27513-27522.
2. Beitner-Johnson D., Nestler E.J. Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J. Neurochem. 57:1991;344-347.
3. Berhow M.T., Hiroi N., Nestler E.J. Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16:1996;4707-4715.
4. Bohn L.M., Belcheva M.M., Coscia C.J. Mitogenic signaling via endogenous κ-opioid receptors in C6 glioma cells: evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade. J. Neurochem. 74:2000;564-573.
5. Boundy V.A., Gold S.J., Messer C.J., Chen J., Son J.H., Joh T.H., Nestler E.J. Regulation of tyrosine hydroxylase promoter activity by chronic morphine in TH9.0-LacZ transgenic mice. J. Neurosci. 18:1998;9989-9995.
6. Ciccocioppo R., Angeletti S., Sanna P.P., Friedbert W., Massi M. Effect of nociceptin/orphanin FQ on the rewarding properties of morphine. Eur. J. Pharmacol. 404:2000;153-159.
7. Ciccocioppo R., Angeletti S., Panocka I., Massi M. Nociceptin/orphanin FQ and drugs of abuse. Peptides. 21:2000;1071-1080.
8. Ciccarone V., Spengler B.A., Meyers M.B., Biedler J.L., Ross R.A. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer. Res. 49:1989;219-225.
9. 2+ in the SH-SY5Y human neuroblastoma cell line. Br. J. Pharmacol. 118:1996;205-207.
10. Connor M., Vaughan C.W., Chieng B., Christie M.J. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurons in vitro. Br. J. Pharmacol. 119:1996;1614-1618.
11. Dawson S.J., Yoon S.O., Chikaraishi D.M., Lillycrop K.A., Latchman D.S. The Oct-2 transcription factor represses tyrosine hydroxylase expression via a heptamer TAATGARAT-like motif in the gene promoter. Nucleic Acids Res. 22:1994;1023-1028.
12. Deans Z., Dawson S.J., Buttery L., Polak J.M., Wallace D., Latchman D.S. Direct evidence that the POU family transcription factor Oct-2 represses the cellular tyrosine hydroxylase gene in neuronal cells. J. Mol. Neurosci. 6:1995;159-167.
13. Devine D.P., Reinscheid R.K., Monsma Jr F.J., Civelli O., Akil H. The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res. 727:1996;225-229.
14. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38:1995;95-137.
15. Di Giannuario A., Pieretti S. Nociceptin differentially affects morphine-induced dopamine release from the nucleus accumbens and nucleus caudate in rats. Peptides. 21:2000;1125-1130.
16. DiStefano P.S., Brown O.M. Biochemical correlates of morphine withdrawal. 1. Characterization in the adrenal medulla and locus coeruleus. J. Pharmacol. Exp. Ther. 233:1985;333-338.
17. Foley K.M. Opioid analgesics in clinical pain management. Herz A., Handbook of Experimental Pharmacology. Opioids II. Vol. 104/II:1993;693-743 Springer-Verlag, Berlin.
18. Fukuda K., Kato S., Morikawa H., Shoda T., Mori K. Functional coupling of the δ-, μ-, and κ-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese Hamster Ovary cells. J. Neurochem. 67:1996;1309-1316.
19. Hao J.X., Wiesenfeld-Hallin Z., Xu X.J. Lack of cross-tolerance between the antinociceptive effect of intrathecal orphanin FQ and morphine in the rat. Neurosci. Lett. 223:1997;49-52.
20. Harrison L.M., Grandy D.K. Opiate modulating properties of nociceptin/orphanin FQ. Peptides. 21:2000;151-172.
21. Jhamandas K.H., Sutak M., Henderson G. Antinociceptive and morphine modulatory actions of spinal orphanin FQ. Can. J. Physiol. Pharmacol. 76:1998;314-324.
22. Kazmi S.M., Mishra R.K. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells. Mol. Pharmacol. 32:1987;109-118.
23. Kest B., Hopkins E., Palmese C.A., Chen Z.P., Mogil J.S., Pintar J.E. Morphine tolerance and dependence in nociceptin/orphanin FQ transgenic knock-out mice. Neuroscience. 104:2001;217-222.
24. Kramer H.K., Simon E.J. μ- and δ-opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization. Neuropharmacology. 39:2000;1707-1719.
25. Kotlinska J., Suder P., Legowska A., Rolka K., Silberring J. Orphanin FQ/nociceptin inhibits morphine withdrawal. Life Sci. 66:2000;119-123.
26. Lane-Ladd S.B., Pineda J., Boundy V.A., Pfeuffer T., Krupinski J., Aghajanian G.K., Nestler E.J. CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J. Neurosci. 17:1997;7890-7901.
27. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
28. Mandyam C.D., Altememi G.F., Standifer K.M. β-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells. Eur. J. Pharmacol. 402:2000;R1-R3.
29. Mathis J.P., Mandyam C.D., Altememi G.F., Pasternak G.W., Standifer K.M. Orphanin FQ/nociceptin and naloxone benzoylhydrazone activate distinct receptors in BE(2)-C human neuroblastoma cells. Neurosci. Lett. 299:2001;173-176.
30. Mogil J.S., Grisel J.E., Zhangs G., Belknap J.K., Grandy D.K. Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ. Neurosci. Lett. 214:1996;131-134.
31. Murphy N.P., Maidment N.T. Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J. Neurochem. 73:1999;179-186.
32. Murphy N.P., Lee Y., Maidment N.T. Orphanin FQ/nociceptin blocks acquisition of morphine place preference. Brain Res. 832:1999;168-170.
33. 14Tyr]-orphanin FQ binding. J. Comp. Neurol. 412:1999;563-605.
34. Norton C.S., Neal C.R., Kumar S., Akil H., Watson S.J. Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems. J. Comp. Neurol. 444:2002;358-368.
35. Okawa H., Hirst R.A., Smart D., McKnight A.T., Lambert D.G. Rat central ORL-1 receptor uncouples from adenylyl cyclase during membrane preparation. Neurosci. Lett. 246:1998;49-52.
36. Ortiz J., Harris H.W., Guitart X., Terwilliger R.Z., Haycock J.W., Nestler E.J. Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J. Neurosci. 15:1995;1285-1297.
37. Pan Z., Hirakawa N., Fields H.L. A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin. Neuron. 26:2000;515-522.
38. Peluso J., Gaveriaux-Ruff C., Matthes H.W.D., Filliol D., Kieffer B.L. Orphanin FQ/nociceptin binds to functionally coupled ORL1 receptors on human immune cell lines and alters peripheral blood mononuclear cell proliferation. Brain Res. Bull. 54:2001;655-660.
39. Reinscheid R.K., Higelin J., Henningsen R.A., Monsma F.J. Jr., Civelli O. Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities. J. Biol. Chem. 273:1998;1490-1495.
40. Robbins D.J., Zhen E., Owaki H., Vanderbilt C.A., Ebert D., Geppert T.D., Cobb M.H. Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. J. Biol. Chem. 268:1993;5097-5106.
41. Rossi G.C., Perlmutter M., Leventhal L., Talatti A., Pasternak G.W. Orphanin FQ/nociceptin analgesia in the rat. Brain Res. 792:1998;327-330.
42. Schulz S., Hollt V. Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine-dependent rats in vivo. Eur. J. Neurosci. 10:1998;1196-1201.
43. Sim-Selley L.J., Selley D.E., Vogt L.J., Childers S.R., Martin T.J. Chronic heroin self-administration desensitizes μ opioid receptor-activated G-proteins in specific regions of rat brain. J. Neurosci. 20:2000;4555-4562.
44. Spanagel R., Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci. 22:1999;521-527.
45. 3 binding sites expressed in BE(2)-C neuroblastoma cells. J. Pharmacol. Exp. Ther. 270:1994;1246-1255.
46. D.R. Thakker, K.M. Standifer, Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between μ and ORL1 receptors following prolonged agonist exposure, Neuropharmacology (in press).
47. Trapaidze N., Gomes I., Cvejic S., Bansinath M., Devi L.A. Opioid receptor endocytosis and activation of MAP kinase pathway. Mol. Brain Res. 76:2000;220-228.
48. Yuan L., Han Z., Chang J.-K., Han J.-S. Accelerated release and production of orphanin FQ in brain of chronic morphine tolerant rats. Brain Res. 826:1999;330-334.